The multi-centre, randomised, double-blind RUBY and TOPAZ studies are assessing the therapy’s performance against allopurinol ...

An expert in gout clinical trials questions whether ethical considerations for such trials need updating to emphasize patient ...

Urica Therapeutics, a majority-owned subsidiary of Fortress, reported that Crystalys Therapeutics has dosed the first patients in two global Phase 3 trials evaluating dotinurad, a once-daily oral ...

Shanton Pharma, a clinical-stage biotech developing a novel treatment for gout, today announced the successful completion of ...

In patients with gout, a novel prediction tool that relies on weight and creatinine clearance successfully identified the ...

Snakes offer a surprising solution to kidney stones and gout. Unlike humans, reptiles excrete uric acid as tiny, smooth ...

These Phase 3 clinical studies are designed to evaluate the safety and efficacy of dotinurad compared to an active control ...

Results of a Phase 2a dose escalating study of lingdolinurad (ABP-671) for chronic gout, which enrolled patients with mild to moderate renal impairment, showed the URAT1 inhibitor lowered serum uric ...

Approximately 950,000 people in Germany have been diagnosed with gout. About eight out of ten patients are male, with the ...

Gout Gout has won the last races of his school career and been mobbed at the GPS Track and Field Championships. Watch replays ...

Atom’s lingdolinurad (ABP-671), a URAT1 inhibitor, is in late stage global clinical trials for chronic gout and ABP-745, an anti-inflammatory drug, is in multi-country Phase 2 trials for acute gout ...

The final thesis of Professor Lim Soo's team of the Department of Endocrine Metabolism at Bundang Seoul National University ...